Vaso Corporation
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Jun Ma
- Full Time Employees
- 298
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 137 Commercial Street Plainview NY United States of America 11803
- IPO Date
- Aug 18, 1995
- CIK
- 0000839087
- Website
- vasocorporation.com
- Similar Companies
- Business
- Vaso Corporation (VASO) operates as a diversified medical technology company in the healthcare equipment and information technology industries, providing noninvasive monitoring and therapeutic devices, diagnostic imaging equipment sales services, and managed IT systems through three wholly owned subsidiaries. VasoTechnology offers managed healthcare software solutions, including diagnostic imaging applications; managed network infrastructure such as routers, switches, and core equipment; managed network transport via FCC-licensed carrier reselling; and managed security services partnering with firms like IBM and Palo Alto Networks, serving enterprises and healthcare customers with mission-critical applications across the U.S. and globally. VasoHealthcare provides professional sales representation for General Electric Healthcare diagnostic imaging equipment, targeting middle-market providers including independent hospitals, imaging centers, and multispecialty clinics throughout the continental U.S.; VasoMedical designs, manufactures, sells, and services proprietary medical devices for noninvasive cardiovascular monitoring, diagnosis, and treatment, with engineering and production primarily in China and sales managed from U.S. and China offices or international partners. Founded in 1987 and formerly known as Vasomedical, Inc., until its name change in November 2016, the company maintains headquarters at 137 Commercial Street, Plainview, New York. In November 2025, Vaso Corporation announced an agreement to divest its VasoHealthcare IT subsidiary to Nanox Imaging Ltd. for up to $800,000, including $200,000 in cash at closing and up to $600,000 in performance-based earnouts over two years tied to revenue retention, enabling Nanox to integrate VHC IT's operational infrastructure with its AI solutions for U.S. expansion while streamlining Vaso's focus on core operations. The company reported record revenue for 2024 amid strategic investments, sustaining profitability and free cash flow generation to support organic growth and potential further partnerships or acquisitions.
Vaso Stock Gains Post Q1 Earnings, Deferred Revenue Grows
Vaso Corporation Announces Financial Results for First Quarter of 2026
Vaso (OTCMKTS:VASO) Stock Price Passes Above 200-Day Moving Average – Time to Sell?
Vaso Stock Declines Post Q4 Earnings Despite Revenue Growth
Vaso (OTCMKTS:VASO) Stock Passes Above 200 Day Moving Average – Here’s Why
Vaso (OTCMKTS:VASO) Shares Pass Above 200 Day Moving Average – Should You Sell?
Vaso (OTCMKTS:VASO) Shares Pass Above Two Hundred Day Moving Average – What’s Next?
Expanse Studios Launches First Celebrity-Branded Slot ‘VASO Psycho' with MMA Icon Vaso Bakocevic
Contrasting Vaso (OTCMKTS:VASO) & IDEXX Laboratories (NASDAQ:IDXX)
Vaso (OTCMKTS:VASO) Stock Price Passes Above 200-Day Moving Average – Should You Sell?
Analyzing 908 Devices (NASDAQ:MASS) & Vaso (OTCMKTS:VASO)
Vaso Corporation Announces Fifth Extension of Sales Representation Agreement with GE HealthCare
Vaso Stock Up Following Strong Q3 Earnings and Profit Turnaround
Vaso Corporation Announces Divestiture of Subsidiary
Nanox Reaches Agreement with Vaso Corporation to Acquire VasoHealthcare IT, Accelerating U.S. Rollout of AI Solutions
Vaso Corporation Announces Financial Results for Third Quarter of 2025
Telescope Innovations Appoints Vaso Vlachos as Chief Operating Officer
Vaso Stock Down Following Q2 Earnings as Revenue and Margins Fall
Vaso Stock Slips Post Q1 Earnings Despite Record Revenue Growth
Vaso Corporation Announces Financial Results for First Quarter of 2025